AR025111A1 - Metodos y composiciones para tratar trastornos de ansiedad generalizada - Google Patents
Metodos y composiciones para tratar trastornos de ansiedad generalizadaInfo
- Publication number
- AR025111A1 AR025111A1 ARP000104190A ARP000104190A AR025111A1 AR 025111 A1 AR025111 A1 AR 025111A1 AR P000104190 A ARP000104190 A AR P000104190A AR P000104190 A ARP000104190 A AR P000104190A AR 025111 A1 AR025111 A1 AR 025111A1
- Authority
- AR
- Argentina
- Prior art keywords
- compositions
- methods
- generalized anxiety
- anxiety disorders
- treat generalized
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Métodos y composiciones que comprenden una dosis muy baja de ciclobenzaprina o metabolito de la misma para prevenir y tratar el trastorno de ansiedadgeneralizada. La presente se refiere además a métodos y composiciones para tratar y prevenirsíntomas asociados con el trastorno de ansiedad generalizada,usando una dosis muy baja de ciclobenzaprina.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14888199P | 1999-08-13 | 1999-08-13 | |
US21192200P | 2000-06-16 | 2000-06-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR025111A1 true AR025111A1 (es) | 2002-11-06 |
Family
ID=26846257
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000104190A AR025111A1 (es) | 1999-08-13 | 2000-08-11 | Metodos y composiciones para tratar trastornos de ansiedad generalizada |
Country Status (13)
Country | Link |
---|---|
US (1) | US6358944B1 (es) |
EP (1) | EP1202721A1 (es) |
JP (1) | JP2003506483A (es) |
AR (1) | AR025111A1 (es) |
AU (1) | AU6634000A (es) |
BR (1) | BR0013122A (es) |
CA (1) | CA2380373A1 (es) |
ES (1) | ES2212737B1 (es) |
GB (1) | GB2368283A (es) |
HK (2) | HK1047692A1 (es) |
IL (1) | IL147778A0 (es) |
MX (1) | MXPA02001568A (es) |
WO (1) | WO2001012174A1 (es) |
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6733789B1 (en) | 1999-01-21 | 2004-05-11 | Biovail Laboratories, Inc. | Multiparticulate bisoprolol formulation |
US6395788B1 (en) * | 1999-08-13 | 2002-05-28 | Vela Pharmaceuticals, Inc. | Methods and compositions for treating or preventing sleep disturbances and associated illnesses using very low doses of cyclobenzaprine |
US20040185099A1 (en) * | 2000-01-20 | 2004-09-23 | Biovail Laboratories, Inc. | Multiparticulate bisoprolol formulation |
CA2446904A1 (en) * | 2001-05-24 | 2003-04-03 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
US7189757B2 (en) * | 2001-10-16 | 2007-03-13 | Hypnion, Inc. | Treatment of sleep disorders using CNS target modulators |
EP1443929A4 (en) * | 2001-10-16 | 2008-02-06 | Hypnion Inc | TREATMENT OF CNS DISTURBANCES WITH CNS TARGET MODULATORS |
US20030118652A1 (en) * | 2001-11-15 | 2003-06-26 | John Kelly | Methods and compositions for use of (S)-bisoprolol |
US20030091633A1 (en) * | 2001-11-15 | 2003-05-15 | John Kelly | Methods and compositions for use of (S)-bisoprolol |
MXPA04011529A (es) * | 2002-04-24 | 2005-08-15 | Cypress Bioscience Inc | Prevencion y tratamiento de trastornos somaticos funcionales, incluyendo trastornos relacionados con la tension. |
WO2004016272A1 (en) * | 2002-08-14 | 2004-02-26 | Pharmacia & Upjohn Company Llc | Use of reboxetine for the treatment of hot flashes |
US20060217367A1 (en) * | 2004-07-01 | 2006-09-28 | Astrazeneca Ab | Method of treating anxiety disorders |
NZ527142A (en) * | 2003-07-23 | 2006-03-31 | Douglas Pharmaceuticals Ltd | A stable suspension formulation |
US7387793B2 (en) | 2003-11-14 | 2008-06-17 | Eurand, Inc. | Modified release dosage forms of skeletal muscle relaxants |
GB0400895D0 (en) * | 2004-01-15 | 2004-02-18 | Smithkline Beecham Corp | Chemical compounds |
US7517908B2 (en) * | 2004-05-21 | 2009-04-14 | Duke University | Method for augmenting the effects of serotonin reuptake inhibitors |
AR050253A1 (es) * | 2004-06-24 | 2006-10-11 | Smithkline Beecham Corp | Compuesto derivado de indazol carboxamida, composicion que lo comprende y su uso para la preparacion de un medicamento |
NL1026634C2 (nl) * | 2004-07-12 | 2006-01-16 | Willem Jacob Van Der Burg | Psychofarmaceutisch preparaat en werkzame stof daarin. |
US8063071B2 (en) * | 2007-10-31 | 2011-11-22 | GlaxoSmithKline, LLC | Chemical compounds |
US20070087055A1 (en) * | 2005-10-14 | 2007-04-19 | David Jan | Directly compressible extended release alprazolam formulation |
WO2007056618A1 (en) * | 2005-11-10 | 2007-05-18 | Board Of Supervisors Of Louisiana State University & Agricultural & Mechanical College | Compositions and methods for the treatment of addiction and other neuropsychiatric disorders |
WO2007062318A2 (en) * | 2005-11-18 | 2007-05-31 | Smithkline Beecham Corporation | Chemical compounds |
US8357114B2 (en) | 2006-01-06 | 2013-01-22 | Acelrx Pharmaceuticals, Inc. | Drug dispensing device with flexible push rod |
US8252328B2 (en) | 2006-01-06 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
US8252329B2 (en) | 2007-01-05 | 2012-08-28 | Acelrx Pharmaceuticals, Inc. | Bioadhesive drug formulations for oral transmucosal delivery |
US9289583B2 (en) * | 2006-01-06 | 2016-03-22 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
US8753308B2 (en) | 2006-01-06 | 2014-06-17 | Acelrx Pharmaceuticals, Inc. | Methods for administering small volume oral transmucosal dosage forms using a dispensing device |
US8202535B2 (en) | 2006-01-06 | 2012-06-19 | Acelrx Pharmaceuticals, Inc. | Small-volume oral transmucosal dosage forms |
US8865743B2 (en) | 2006-01-06 | 2014-10-21 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
US9066847B2 (en) * | 2007-01-05 | 2015-06-30 | Aceirx Pharmaceuticals, Inc. | Storage and dispensing devices for administration of oral transmucosal dosage forms |
US8535714B2 (en) | 2006-01-06 | 2013-09-17 | Acelrx Pharmaceuticals, Inc. | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain |
US7645750B2 (en) * | 2006-12-13 | 2010-01-12 | Yung Shin Pharmaceutical Ind. Co., Ltd. | Method of treating symptoms of hormonal variations |
GB0701970D0 (en) * | 2007-02-01 | 2007-03-14 | Wilson Stuart | Treatment of protein aggregation diseases |
AR065804A1 (es) * | 2007-03-23 | 2009-07-01 | Smithkline Beecham Corp | Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento |
US8198305B2 (en) * | 2007-04-13 | 2012-06-12 | Concert Pharmaceuticals Inc. | 1,2-benzisoxazol-3-yl compounds |
KR101606944B1 (ko) * | 2007-08-07 | 2016-03-28 | 아셀알엑스 파마슈티컬스 인코퍼레이티드 | 경구 경점막 투여형을 사용한 시술시 진정과 무통을 위한 조성물 및 방법 |
US8420624B2 (en) * | 2007-12-04 | 2013-04-16 | Yung Shin Pharm. Ind. Co., Ltd. | Methods for treating or preventing symptoms of hormonal variations |
US20110092493A1 (en) * | 2008-09-24 | 2011-04-21 | Clark Levi | Dose-controlled transdermal promethazine compositions and methods of use |
US8945592B2 (en) * | 2008-11-21 | 2015-02-03 | Acelrx Pharmaceuticals, Inc. | Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same |
US9498440B2 (en) | 2009-05-22 | 2016-11-22 | Inventia Healthcare Private Limited | Extended release pharmaceutical compositions |
US20110091544A1 (en) * | 2009-10-16 | 2011-04-21 | Acelrx Pharmaceuticals, Inc. | Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting |
NO2501234T3 (es) | 2009-11-20 | 2018-02-10 | ||
US20110319389A1 (en) | 2010-06-24 | 2011-12-29 | Tonix Pharmaceuticals, Inc. | Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine |
ES2703255T3 (es) | 2010-10-22 | 2019-03-07 | Univ Duke | Formulaciones de liberación lenta de 5-hidroxitriptófano como un complemento para terapias pro-serotoninérgicas |
US20120232159A1 (en) | 2011-03-07 | 2012-09-13 | Tonix Pharmaceuticals, Inc. | Methods and Compositions for Treating Depression using Cyclobenzaprine |
EP2861223B1 (en) | 2012-06-15 | 2022-08-03 | Tonix Pharma Holdings Limited | Compositions and methods for transmucosal absorption |
US10117936B2 (en) | 2013-03-15 | 2018-11-06 | Tonix Pharma Holdings Limited | Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride |
CN107072968B (zh) | 2014-09-18 | 2021-01-12 | 通尼克斯制药控股有限公司 | 环苯扎林盐酸盐的低共熔混合物配制剂 |
CN110996932A (zh) | 2017-07-13 | 2020-04-10 | 托尼克斯医药控股公司 | 环苯扎林和阿米替林的类似物 |
WO2019116091A1 (en) | 2017-12-11 | 2019-06-20 | Tonix Pharma Holdings Limited | Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions |
BR112021003107A2 (pt) * | 2018-08-20 | 2021-05-11 | Tonix Pharma Holdings Limited | métodos de tratamento de transtorno de estresse agudo e transtorno de estresse pós-traumático |
JP2023554597A (ja) | 2020-11-20 | 2023-12-28 | トニックス ファーマシューティカルズ ホールディング コーポレイション | アルコール使用障害のためのシクロベンザプリン処置 |
KR102397333B1 (ko) * | 2020-12-21 | 2022-05-13 | 주식회사 스탠다임 | 클레마스틴을 포함하는 강박장애, 틱 장애 또는 뚜렛 증후군 예방 또는 치료용 약학 조성물 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1339636A (en) * | 1917-02-23 | 1920-05-11 | Tulloch Thomas Gregorie | Fluid-tight joint for steam-pipes and the like |
GB859187A (en) | 1958-11-25 | 1961-01-18 | United States Borax Chem | Method for preparing substituted tris amino boranes |
CA958643A (en) | 1970-07-07 | 1974-12-03 | Frosst (Charles E.) And Co. | Pharmaceutical compositions containing cyclobenzaprine |
FR2121529A1 (en) * | 1971-01-05 | 1972-08-25 | Merck & Co Inc | Compsns contg cyclobenzaprine and indomethacin - chlordiazepoxide, phenylbutazone oxyphenbutazone or corticosteroid |
US3882246A (en) * | 1971-05-21 | 1975-05-06 | Merck & Co Inc | Treatment of skeletal muscle disorders with cyclobenzaprine |
-
2000
- 2000-08-11 ES ES200250017A patent/ES2212737B1/es not_active Withdrawn - After Issue
- 2000-08-11 BR BR0013122-9A patent/BR0013122A/pt not_active Application Discontinuation
- 2000-08-11 AR ARP000104190A patent/AR025111A1/es unknown
- 2000-08-11 WO PCT/US2000/022026 patent/WO2001012174A1/en not_active Application Discontinuation
- 2000-08-11 IL IL14777800A patent/IL147778A0/xx unknown
- 2000-08-11 MX MXPA02001568A patent/MXPA02001568A/es unknown
- 2000-08-11 AU AU66340/00A patent/AU6634000A/en not_active Abandoned
- 2000-08-11 EP EP00953980A patent/EP1202721A1/en not_active Withdrawn
- 2000-08-11 GB GB0203286A patent/GB2368283A/en not_active Withdrawn
- 2000-08-11 JP JP2001516520A patent/JP2003506483A/ja active Pending
- 2000-08-11 US US09/638,058 patent/US6358944B1/en not_active Expired - Lifetime
- 2000-08-11 CA CA002380373A patent/CA2380373A1/en not_active Abandoned
-
2002
- 2002-10-22 HK HK02107669.3A patent/HK1047692A1/zh unknown
- 2002-10-22 HK HK02107670.0A patent/HK1047693A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
BR0013122A (pt) | 2002-04-30 |
GB0203286D0 (en) | 2002-03-27 |
ES2212737A1 (es) | 2004-07-16 |
IL147778A0 (en) | 2002-08-14 |
HK1047693A1 (zh) | 2003-03-07 |
US6358944B1 (en) | 2002-03-19 |
ES2212737B1 (es) | 2005-10-01 |
AU6634000A (en) | 2001-03-13 |
HK1047692A1 (zh) | 2003-03-07 |
MXPA02001568A (es) | 2002-07-02 |
WO2001012174A1 (en) | 2001-02-22 |
EP1202721A1 (en) | 2002-05-08 |
CA2380373A1 (en) | 2001-02-22 |
JP2003506483A (ja) | 2003-02-18 |
GB2368283A (en) | 2002-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR025111A1 (es) | Metodos y composiciones para tratar trastornos de ansiedad generalizada | |
ES2192156B1 (es) | Composiciones de uso para tratar o prevenir alteraciones del sueño usando dosis muy bajas de ciclobenzaprina. | |
AR044007A1 (es) | Metodos para el tratamiento de la enfermedad de parkinson | |
AR049955A1 (es) | Composiciones y metodos para el tratamiento de trastornos metabolicos | |
AR034746A1 (es) | Combinaciones para el tratamiento de trastornos inflamatorios | |
ES2163090T3 (es) | Uso de toxina botulinica para tratar la cefalea tensional. | |
BR0312232A (pt) | Inibidores de caspases e seus usos | |
UY28041A1 (es) | Metodos de dosis bajas para el tratamiento de trastornos en los cuales la actividad del tnfa es perjudicial. | |
AR026610A1 (es) | Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central | |
AR032349A1 (es) | Uso de neurotoxinas para preparar composiciones farmaceuticas de aplicacion en el tratamiento de trastornos del movimiento | |
BRPI0606393A2 (pt) | prevenção de doenças trombóticas com compostos ativos de vitamina d ou similares do mesmo | |
BR0313371A (pt) | Composto, uso de um composto e método de tratamento de doença | |
DK1091745T3 (da) | Behandling af hyperproliferative forstyrrelser | |
AR035131A1 (es) | Composiciones topicas y metodos para el tratamiento del dolor | |
HN2003000090A (es) | Compuestos que modulan la actividad de ppar | |
CR9392A (es) | O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof | |
BRPI0415953B8 (pt) | formulação de dosagem de liberação controlada e conjunto de formas de dosagem de liberação controlada | |
BR0209327A (pt) | Composição para tratamento de constipação induzida por drogas | |
AR021155A1 (es) | Tratamiento de desordenes neuroticos | |
BR0208405A (pt) | Compostos de diidropirimina substituìdos com ciano e seu uso para tratar doenças | |
BR0313413A (pt) | Uso da vacinação beta amilóide juntamente com um inibidor da cox-2 seletivo para o tratamento da doença de alzheimer | |
UY27018A1 (es) | Derivados de la pirimidina | |
AR031032A1 (es) | Uso de la tolterodina en el tratamiento del asma | |
UY26422A1 (es) | Método para administrar un inhibidor de fosfodiesterasa 4 | |
CR8584A (es) | Piperazinas derivadas de urea para el tratamiento de la endometrosis |